|
|
Other links at Articles > Business of Medicine |
| 1. |
New FDA Orphan Drugs: AVI-4658, SQ109, ATIR
|
|
|
The FDA has granted orphan drug designation to AVI-4658 for the treatment of Duchenne muscular dystrophy, SQ109 for the treatment of tuberculosis, and ATIR for the topical treatment of graft-versus-host disease. Medscape Medical News
|
| 3. |
Galvus Gets Positive EU Opinion
|
|
|
Galvus (vildagliptin; Novartis), a dipeptidyl peptidase-IV (DPP-IV) inhibitor that improves cell responsiveness to glucose, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety concerns. Reuters Health Information
|
| 4. |
U.S. Inspects Few Foreign Drugmakers, Congress Told
|
|
|
U.S. regulators inspect few foreign makers of pharmaceutical ingredients and have no accurate count of how many companies supply the American market, a watchdog arm of Congress said on Thursday. Reuters Health Information
|
|
|